Brief: Biolife Solutions Announces 2022 Fourth Quarter And Full Year Preliminary Unaudited Revenue And Introduces 2023 Revenue Guidance
Jan 9 (Reuters) - Biolife Solutions Inc BLFS.O :
* BIOLIFE SOLUTIONS ANNOUNCES 2022 FOURTH QUARTER AND FULL
YEAR
PRELIMINARY UNAUDITED REVENUE AND INTRODUCES 2023 REVENUE
GUIDANCE
* Q4 REVENUE ROSE 19 PERCENT TO $44.4 MILLION
* INITIAL REVENUE GUIDANCE FOR 2023 OF $188 MILLION TO $202
MILLION
* EXPECTS FULL YEAR POSITIVE ADJUSTED EBITDA AND ADJUSTED
EBITDA
GROWTH IN 2023
* FY2023 REVENUE VIEW $195.4 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn8mvwFBa
Further company coverage: BLFS.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on BioLife Solutions
See all newsFreshworks gains ahead of S&P SmallCap 600 inclusion
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: S&P Dow Jones Indices Freshworks Set To Join S&P Smallcap 600
BioLife Solutions, Inc. reports results for the quarter ended June 30 - Earnings Summary